EugiaTx is a biotechnology company leveraging computational genomics and genome editing to develop tissue-targeting therapies. Its core offering is the TAGHOME platform, a targeted drug delivery system designed to enhance the safety and efficacy of treatments for inflammatory diseases. The company aims to form partnerships with other pharmaceutical and biotech firms to bring these advanced therapeutics to market.
$500.0K
1
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos